Verismo Therapeutics
Research - Philadelphia, Pennsylvania, United States
Verismo Therapeutics Employees
Verismo Therapeutics Senior Management
Verismo Therapeutics Details
Verismo Therapeutics is pioneering the development of novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer, especially non-hematologic malignancies with few effective therapeutic options. Verismo Therapeutic's core technology is built upon CARs that are uniquely engineered to more realistically reflect the natural multichain design of killer immunoglobulin-like receptors (KIRs), an important family of immunologic receptors used by T cells and NK cells. Preclinical studies show that SynKIR™-T cells, created by introducing these KIR-based CARs (KIR-CARs) into T cells, more effectively eliminate aggressive tumors in vivo when compared with T cells bearing traditional 2nd generation CAR designs found in current FDA approved CAR-T cell therapies.
Verismo Therapeutics Technologies
E-commerce Platforms
Squarespace ECommerce
Email Providers
Outlook
Domain Name Services
NSOne
Fonts
Google Font API
Other
Mobile Friendly